中国的生物制药（01177）在早期贸易中增长了3％以上。在出版时，其股票增长了2.66％，至7.72港元，销售额为2.55亿港元。 7月30日，中国的Biofarma建立在Lixin Pharmaceutical Technology（Shanghai），Ltd，该集团的全部财产子公司。 (LXIN PHARMACEUTICALS) and LM-299/MK-2010 "PD-1/VEGF DUAL ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-ANTI-AMTI Anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti anti-anti-anti anti-anti anti-anti anti-anti anti-anti anti-anti anti-anti anti-anti anti-anti anti-anti anti-anti anti-anti anti-anti抗抗Anti-anti抗Anti-anti抗抗Anti-anti抗Anti-anti抗Anti-anti抗Anti-anti抗Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-anti抗Antiti-anti-anti anti-antianti-anti anti anti anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti anti ti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-A Anti-nivel Anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia Anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIA ANATIa anatia阿纳特ia Anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia anatia Anatia anatia anatia anatia Anatia解剖性ranatia ranatia ranatia ranatia ranatia i-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-An Ti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Ani-An Ti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Ai-A nti-atha-atha-anti-anti-anti-ath-atha-athi-athi athi athi athi athi-athi-athi-athi-athi-athi-athi-athi-athi-athi-athi-athi-athi-athi-athi-at-ati-ati-ai-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a 2025年7月29日，桑德（Sand）希望默克（Merck第三季度的Ansfer里程碑为3亿美元。此外，在Telefónica会议问题和会议会议上，默克对分析师的调查回应了LM299项目按计划进行的。 据报道，2024年据报道，Lixin Pharmaceutical和Merck与LM-299达成了全球独家认证协议。根据协议的条款，默克公司将获得LM299的全球开发，生产和营销的独家许可。 Lixin Pharmaceuticals的初始付款为5.88亿美元，最高里程碑将支付27亿美元。 官方NINA Finance帐户 24-最新信息和财务视频的流离失所，以及扫描QR码以关注更多粉丝（Sinafinance）